These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Beta(2)-adrenergic receptor overexpression driven by alpha-MHC promoter is downregulated in hypertrophied and failing myocardium. Sheridan DJ; Autelitano DJ; Wang B; Percy E; Woodcock EA; Du XJ Cardiovasc Res; 2000 Jul; 47(1):133-41. PubMed ID: 10869539 [TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. Bristow MR; Minobe W; Rasmussen R; Larrabee P; Skerl L; Klein JW; Anderson FL; Murray J; Mestroni L; Karwande SV J Clin Invest; 1992 Mar; 89(3):803-15. PubMed ID: 1311717 [TBL] [Abstract][Full Text] [Related]
6. Molecular Changes in Children with Heart Failure Undergoing Left Ventricular Assist Device Therapy. Medina E; Sucharov CC; Nelson P; Miyamoto SD; Stauffer BL J Pediatr; 2017 Mar; 182():184-189.e1. PubMed ID: 27908653 [TBL] [Abstract][Full Text] [Related]
7. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading? Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865 [TBL] [Abstract][Full Text] [Related]
8. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Boluyt MO; O'Neill L; Meredith AL; Bing OH; Brooks WW; Conrad CH; Crow MT; Lakatta EG Circ Res; 1994 Jul; 75(1):23-32. PubMed ID: 8013079 [TBL] [Abstract][Full Text] [Related]
9. Gene expression and β-adrenergic signaling are altered in hypoplastic left heart syndrome. Miyamoto SD; Stauffer BL; Polk J; Medway A; Friedrich M; Haubold K; Peterson V; Nunley K; Nelson P; Sobus R; Stenmark KR; Sucharov CC J Heart Lung Transplant; 2014 Aug; 33(8):785-93. PubMed ID: 24793904 [TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: transition from hypertrophy to failure. DiPaola NR; Sweet WE; Stull LB; Francis GS; Schomisch Moravec C J Mol Cell Cardiol; 2001 Jun; 33(6):1283-95. PubMed ID: 11444930 [TBL] [Abstract][Full Text] [Related]
11. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Reiser PJ; Portman MA; Ning XH; Schomisch Moravec C Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1814-20. PubMed ID: 11247796 [TBL] [Abstract][Full Text] [Related]
12. Myosin heavy chain gene expression in human heart failure. Nakao K; Minobe W; Roden R; Bristow MR; Leinwand LA J Clin Invest; 1997 Nov; 100(9):2362-70. PubMed ID: 9410916 [TBL] [Abstract][Full Text] [Related]
13. Analysis of gene expression patterns in small amounts of human ventricular myocardium by a multiplex RNase protection assay. Mittmann C; Münstermann U; Weil J; Böhm M; Herzig S; Nienaber C; Eschenhagen T J Mol Med (Berl); 1998 Feb; 76(2):133-40. PubMed ID: 9500679 [TBL] [Abstract][Full Text] [Related]
14. Metabolic gene expression in fetal and failing human heart. Razeghi P; Young ME; Alcorn JL; Moravec CS; Frazier OH; Taegtmeyer H Circulation; 2001 Dec; 104(24):2923-31. PubMed ID: 11739307 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart. Zisman LS; Asano K; Dutcher DL; Ferdensi A; Robertson AD; Jenkin M; Bush EW; Bohlmeyer T; Perryman MB; Bristow MR Circulation; 1998 Oct; 98(17):1735-41. PubMed ID: 9788827 [TBL] [Abstract][Full Text] [Related]
16. Alterations in myosin heavy chain isoform gene expression during the transition from compensatory hypertrophy to congestive heart failure in rats. Huang Y; Liu H; Li Y Chin Med J (Engl); 2001 Feb; 114(2):183-5. PubMed ID: 11780203 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure. Razeghi P; Young ME; Cockrill TC; Frazier OH; Taegtmeyer H Circulation; 2002 Jul; 106(4):407-11. PubMed ID: 12135937 [TBL] [Abstract][Full Text] [Related]
18. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Zisman LS; Keller RS; Weaver B; Lin Q; Speth R; Bristow MR; Canver CC Circulation; 2003 Oct; 108(14):1707-12. PubMed ID: 14504186 [TBL] [Abstract][Full Text] [Related]
19. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts. Linck B; Bokník P; Eschenhagen T; Müller FU; Neumann J; Nose M; Jones LR; Schmitz W; Scholz H Cardiovasc Res; 1996 Apr; 31(4):625-32. PubMed ID: 8689655 [TBL] [Abstract][Full Text] [Related]
20. Left ventricular aneurysm repair in rats: structural, functional, and molecular consequences. Sakaguchi G; Young RL; Komeda M; Yamanaka K; Buxton BF; Louis WJ J Thorac Cardiovasc Surg; 2001 Apr; 121(4):750-61. PubMed ID: 11279418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]